Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1244]
News [2385]
Articles [91]
Editorials [4]
Conferences [117]
elearning [25]
The role of afatinib in patients with EGFR NSCLC
Dr Antonio Passaro - European Institute of Oncology, Milan, Italy
The role of afatinib in patients with EGFR NSCLC ( Dr Antonio Passaro - European Institute of Oncology, Milan, Italy )
18 Apr 2019
KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after...
Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea
KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after two or more lines of prior therapy ( Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea )
15 Apr 2019
TATTON: Updated results for patients with EGFR-mutant NSCLC
Prof Leica Sequist - Massachusetts General Hospital, Boston, USA
TATTON: Updated results for patients with EGFR-mutant NSCLC ( Prof Leica Sequist - Massachusetts General Hospital, Boston, USA )
11 Apr 2019
Cancer preventive vaccine showed promising results in preclinical model of...
Prof Steven Lipkin - Weill Cornell Medical College, New York, USA
Cancer preventive vaccine showed promising results in preclinical model of Lynch syndrome ( Prof Steven Lipkin - Weill Cornell Medical College, New York, USA )
11 Apr 2019
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate...
Prof Karim Fizazi, Dr Eleni Efstathiou
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou )
15 Mar 2019
Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma
Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK
Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma ( Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK )
19 Feb 2019
ASCO GU 2019: Updates on treatment and management of bladder cancer
Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim...
ASCO GU 2019: Updates on treatment and management of bladder cancer ( Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim Bellmunt, Dr Andrea Necchi )
15 Feb 2019
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer
Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas...
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas Mottet )
15 Feb 2019
Analysis of acute toxicity from PACE-B: Comparing SBRT to CFMHRT for localised...
Dr Nicholas van As - The Royal Marsden NHS Foundation Trust, London, UK
Analysis of acute toxicity from PACE-B: Comparing SBRT to CFMHRT for localised prostate cancer ( Dr Nicholas van As - The Royal Marsden NHS Foundation Trust, London, UK )
15 Feb 2019
ASCO GU 2019 renal highlights
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2019 renal highlights ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Feb 2019
Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer
Dr Arjun Balar - NYU Langone Health, New York City, USA
Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer ( Dr Arjun Balar - NYU Langone Health, New York City, USA )
14 Feb 2019
BGICC 2019
BGICC 2019 ( )
28 Jan 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation